UK commission proposes new framework to regulate AI-driven medical tools

On Thursday, a UK commission presented a set of 44 recommendations for governing the use of artificial intelligence in medical practice. The proposals suggest a staged authorization process for new AI algorithms, enabling gradual market entry rather than a single, permanent clearance. Additionally, the commission recommends establishing one outlet's reporting mechanism where clinicians can submit data on how AI tools perform, including any failures or adverse impacts on care.

By doing so, regulators aim to continuously monitor device safety as models evolve and adapt to different clinical settings. The framework seeks to capture AI's potential, such as processing large volumes of diabetic eye scans, while safeguarding patient outcomes and promoting equitable access. The recommendations are intended to guide UK health authorities as they develop ongoing oversight of AI-enabled medical devices.